Skip links

Insights

Every day we work to continue to earn your trust and confidence.

Our daily discipline includes researching and writing a top-down look at the markets, called Morning Notes.

You’ll be able to read part of the most recent edition here, daily. Join our subscribers to get the full edition delivered to you directly.

Morning Notes — Vaccine Implications

Morning Notes — Vaccine Implications

: Interim data from the Phase 3 PFE/BNTX study are expected late next month with Phase 3 MRNA results shortly thereafter and an update from Oxford/AZNA sometime in November. These are the three frontrunners, but there are currently ~38 vaccines undergoing human clinical evaluations and another ~150 in preclinical development.